| Stage | EXLS | % of rev | VIAV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $634M | 100.00% | $443M | 100.00% | EXLS ×1.43 |
| Gross profit | $241M | 38.04% | $262M | 59.06% | VIAV +21.0pp |
| Operating income | $89M | 14.02% | $61M | 13.83% | EXLS +0.2pp |
| Pre-tax income | $87M | 13.67% | $44M | 9.82% | EXLS +3.9pp |
| Net income | $69M | 10.85% | $33M | 7.38% | EXLS +3.5pp |
| Stage | EXLS | VIAV | Gap · A − B |
|---|---|---|---|
| Revenue | $634M100.00% | $443M100.00% | EXLS ×1.43 |
| Gross profit | 38.04%$241M | 59.06%$262M | VIAV +21.0pp |
| Operating income | 14.02%$89M | 13.83%$61M | EXLS +0.2pp |
| Pre-tax income | 13.67%$87M | 9.82%$44M | EXLS +3.9pp |
None
No disclosed counterparties: EXLS.
| Net income |
| 10.85%$69M |
| 7.38%$33M |
| EXLS +3.5pp |